CREB-binding protein and p300/CBP-associated factor are transcriptional coactivators of the p53 tumor suppressor protein

Cancer Research

Volumn 57, Issue 17, 1997, Pages 3693-3696

  Scolnick, Daniel M ^a   Chehab, Nabil H ^a   Stavridi, Elena S ^a   Lien, Marcus C ^a   Caruso, Loretta ^a   Moran, Elizabeth ^b   Berger, Shelley L ^a   Halazonetis, Thanos D ^a,c  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b TEMPLE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c WISTAR INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; PROTEIN P53;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CHROMATIN STRUCTURE; ENZYME ACTIVITY; GENE MUTATION; GENE TARGETING; GENETIC CODE; MULTIGENE FAMILY; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; TRANSACTIVATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

BINDING SITES; BREAST NEOPLASMS; CREB-BINDING PROTEIN; CYCLIN-DEPENDENT KINASE INHIBITOR P21; CYCLINS; HUMANS; NUCLEAR PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0030880936     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Lewin, B. Commitment and activation at Pol II promoters: a tail of protein-protein interactions. Cell, 61: 1161-1164, 1990.
2. Brownell, J. E., Zhou, J., Ranalli, T., Kobayashi, R., Edmondson, D. G., Roth, S. Y., and Allis, C. D. Tetrahymena histone acetyltransferase A: a homologue to yeast Gcn5p linking histone acetylation to gene activation. Cell, 84: 843-851, 1996.
3. Bannister, A. J., and Kouzarides, T. The CBP co-activator is a histone acetyltransferase. Nature (Lond.), 384: 641-643, 1996.
4. Ogryzko, V. V., Schiltz, R. L., Russanova, V., Howard, B. H., and Nakatani, Y. The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87: 953-959, 1996.
5. Yang, X-J., Ogryzko, V. V., Nishikawa, J., Howard, B. H., and Nakatani, Y. A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A. Nature (Lond.), 382: 319-324, 1996.
6. Chrivia, J. C., Kwok, R. P. S., Lamb, N., Hagiwara, M., Montminy, M. R., and Goodman, R. H. Phosphorylated CREB binds specifically to the nuclear protein CBP. Nature (Lond.), 365: 855-859, 1993.
7. Arany, Z., Newsome, D., Oldread, E., Livingston, D. M., and Eckner, R. A family of transcriptional adaptor proteins targeted by the E1A oncoprotein. Nature (Lond.), 374: 81-84, 1995.
8. Lundblad, J. R., Kwok, R. S. P., Laurance, M. E., Harter, M. L., and Goodman, R. H. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP. Nature (Lond.), 374: 85-88, 1995.
9. Janknecht, R., and Hunter, T. Transcriptional control: versatile molecular glue. Curr. Biol., 6: 951-954, 1996.
10. Levine, A. J. p53, the cellular gatekeeper for growth and division. Cell, 88: 323-331, 1997.
11. Candau, R., Scolnick, D. M., Darpino, P., Ying, C. Y., Halazonetis, T. D., and Berger, S. L. Two tandem and independent sub-activation domains in the amino terminus of p53 require the adaptor complex for activity. Oncogene, in press, 1997.
12. Waterman, M. J. F., Waterman, J. L. F., and Halazonetis, T. D. An engineered four-stranded coiled coil substitutes for the tetramerization domain of wild-type p53 and alleviates transdominant inhibition by tumor-derived p53 mutants. Cancer Res., 56: 158-163, 1996.
13. Fan, S., Smith, M. L., Rivet, D. J., Duba, D., Zhan, Q., Kohn, K. W., and Fornace, A. J., Jr. Disruption of p53 function sensitizes breast cancer MCF-7 cells to cisplatin and pentoxifylline. Cancer Res., 55: 1649-1654, 1995.
14. Perkins, N. D., Felzien, L. K., Betts, J. C., Leung, K., Beach, D. H., and Nabel, G. J. Regulation of NF-KB by cyclin-dependent kinases associated with the p300 coactivator. Science (Washington DC), 275: 523-527, 1997.
15. El-Deiry, W. S., Tokino, T., Velculescu, V. E., Levy, D. B., Parsons, R., Trent, J. M., Lin, D., Mercer, W. E., Kinzler, K. W., and Vogelstein, B. WAFI, a potential mediator of p53 tumor suppression. Cell, 75: 817-825, 1993.
16. Yuan, W., Condorelli, G., Caruso, M., Felsani, A., and Giordano, A. Human p300 protein is a coactivator for the transcription factor MyoD. J. Biol. Chem., 271: 9009-9013, 1996.
17. Steegenga, W. T., van Laar, T., Riteco, N., Mandarino, A., Shvarts, A., van der Eb, A. J., and Jochemsen, A. G. Adenovirus E1A proteins inhibit activation of transcription by p53. Mol. Cell. Biol., 16: 2101-2109, 1996.
18. Somasundaram, K., and El-Deiry, W. S. Inhibition of p53-mediated transactivation and cell cycle arrest by E1A through its p300/CBP-interacting region. Oncogene, 14: 1047-1057, 1997.
19. Sang, N., Avantaggiati, M. L., and Giordano, A. Roles of p300, pocket proteins, and hTBP in E1A-mediated transcriptional regulation and inhibition of p53 transactivation activity. J. Cell. Biochem., 66: 277-285, 1997.
20. Wang, H-G. H., Moran, E., and Yaciuk, P. E1A promotes association between p300 and pRb in multimeric complexes required for normal biological activity. J. Virol., 69: 7917-7924, 1995.
21. Thut, C. J., Chen, J-L., Klemm, R., and Tjian, R. p53 transcriptional activation mediated by coactivators TAFII40 and TAFII60. Science (Washington DC), 267: 100-104, 1995.
22. Lu, H., and Levine, A. J. Human TAFII31 protein is a transcriptional coactivator of the p53 protein. Proc. Natl. Acad. Sci. USA, 92: 5154-5158, 1995.
23. Xie, X., Kokubo, T., Cohen, S. L., Mirza, U. A., Hoffmann, A., Chait, B. T., Roeder, R. G., Nakatani, Y., and Burley, S. K. Structural similarity between TAFs and the heterotetrameric core of the histone octamer. Nature (Lond.), 380: 316-322, 1996.
24. Lin, J., Chen, J., Elenbaas, B., and Levine, A. Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein. Genes Dev., 8: 1235-1246, 1994.
25. Wyllie, F. S., Haughton, M. F., Bond, J. A., Rowson, J. M., Jones, C. J., and Wynford-Thomas, D. S phase cell-cycle arrest following DNA damage is independent of the p53/p21waf1 signalling pathway. Oncogene, 12: 1077-1082, 1996.
26. Gu, W., Shi, X-L., and Roeder, R. G. Synergistic activation of transcription by CBP and p53. Nature (Lond.), 387: 819-823, 1997.
27. Lill, N. L., Grossman, S. R., Ginsberg, D., DeCaprio, J., and Livingston, D. M. Binding and modulation of p53 by p300/CBP coactivators. Nature (Lond.), 387: 823-827, 1997.
28. Avantaggiati, M. L., Ogryzko, V., Gardner, K., Giordano, A., Levine, A. S., and Kelly, K. Recruitment of p300/CBP in p53-dependent signal pathways. Cell, 89: 1175-1184, 1997.